Loading chat...
AR SB576
Bill
Status
4/18/2025
Primary Sponsor
Breanne Davis
Click for details
AI Summary
-
Expands Arkansas Medicaid coverage for continuous glucose monitors (CGMs) by removing the requirement that patients use insulin more than two times daily, replacing it with insulin use "in accordance with Medicare policy"
-
Adds eligibility for CGM coverage for patients with evidence of Level 2 or Level 3 hypoglycemia, regardless of insulin frequency
-
Extends CGM coverage to individuals diagnosed with glycogen storage disease type 1a
-
Applies to patients with type 1 diabetes or any other type of diabetes meeting the specified criteria
-
Approved on April 16, 2025 as Act 623 of the Regular Session
Legislative Description
To Amend The Coverage Of Continuous Glucose Monitors Within The Arkansas Medicaid Program.
Last Action
Notification that SB576 is now Act 623
4/18/2025